Skip to main content

Table 1

From: Patient-derived organoids (PDOs) as a novel in vitro model for neuroblastoma tumours

 

PDO1

mean %

PDO2

mean %

PDO3

mean %

PDO4

mean %

PDO5

mean %

CD56 (NCAM)

14.6

92.48

93.50

92.97

94.60

CD133

58.4

1.70

3.60

2.4

2.67

CD117 (c-kit)

6.1

0.50

6.17

9.5

0.30

CD24

10.7

93.74

93.48

93.35

96.78

CD15-CD29-CD24+ (ND)

0.04

70.81

72.16

77.63

91.47

CD14

0.3

1.2

0.6

0

0

CD20

1.2

0.3

1.35

0.75

0.95

CD45

2.4

1.65

2.85

1.70

0.80

  1. Data are presented as mean percentage of N = 3 independent experiments
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us